AUPH.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
Comparison for AUPH, Aurinia Pharmaceuticals Inc
The comparison is made between AUPH and the comparison stocks RMT, GAM and CLMT
Sales
company | revenue | gross income | profit margin | income before tax |
---|---|---|---|---|
AUPH | 34.41M | 33.99M | 98.78 | -25.77M |
RMT | 0.0 | 0.0 | 0.0 | |
GAM | 0.0 | 0.0 | 0.0 | |
CLMT | 2.04B | 261.6M | 12.84 | 100.4M |
For the financial year Jun 30,23, Aurinia Pharmaceuticals Inc sales were $34.41 million and 94.93% under the average of $679.07 million After cost of goods, and selling and general costs, gross income were $33.99 million and 61.02% lower than the average of $87.2 million The profit margin were a lot and the highest and nan,% higher than the average of nan,%
Assets
In the year ending in Jun 30,23, Aurinia Pharmaceuticals Inc net current assets were $381.6 million and above the other companies and -355.14% higher than the average of -$149.57 million This consists of current assets, which were $423.65 million and 41.96% higher than the average of $298.44 million, less current liabilities, which were $42.05 million and 90.61% under the average of $448.0 millionContributing to the current assets was Cash and Short term assets which were 85.34% and above the other companies and a lot higher than the average of 0.69%, recievables (were 4.5% and 90.54% under the average of 47.54%) and inventory (were 7.49% and 56.65% below the averarge of 17.28%) Contributing to the current liabilities were accounts payable (were 8.75% and 79.31% under the average of 42.31%) and short term debt (were 2.25% and 56.49% lower than the average of 5.17%)
As a multiple of net assets, current liabilities were 10.77% and nan,% below the averarge of a lot. Current liabilities as days of sales represents were 446.01 and 88.56% higher than CLMT at 236.54.
In terms of days of sales, accounts receivables were 202.03 and 224.22% higher than CLMT at 62.31
Long term assets
In the year ending in Jun 30,23, Aurinia Pharmaceuticals Inc net assets were $390.41 million and 1.79% under the average of $397.53 million This consists of current assets, which were $451.76 million and 67.85% under the average of $1404.99 million, less current liabilities, which were $61.35 million and 93.91% lower than the average of $1007.46 million
Contributing to the total assets were Plant and Equipment (were 0.85% and the highest and nan,% higher than the average of nan,%) and tangible assets(were 86.42% and nan,% under the average of a lot) Contributing to the total libiatilites were long term debt (were 0.0% and lower than the other companies and nan,% lower than the average of $nan,) and
As a multiple of total assets, total liabilities were 13.58% and nan,% above the average of nan,%.
name | total assets | total liabs | cur assets | cur liabs | days AR |
---|---|---|---|---|---|
AUPH | 451.76M | 61.35M | 423.65M | 42.05M | 202.03 |
RMT | 0.0 | 0.0 | 27.65M | 23.17M | |
GAM | 1410.17M | 19.97M | 4.26M | 642.61K | |
CLMT | 2.8B | 3.0B | 863.4M | 1320.2M | 62.31 |
Plots
``` ```